Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Classification & Diagnosis of Granulomatosis with Polyangiitis

Harry E. Subramanian, Ravi Sutaria, MD, & Fotios Koumpouras, MD  |  Issue: August 2018  |  August 16, 2018

The presence of a mitral vegetation on echo­cardiogram in our patient was a key finding that made differentiation between infective endocarditis and ANCA-associated vasculitis difficult. Cardiac involvement in GPA is rarer than involvement of other organ systems, with a prevalence reported in major studies ranging from 3.3% to 13%.11-13 However, the findings of these studies are inconsistent regarding the presence of any difference in outcomes between patients with cardiac involvement compared with those without. ANCA-associated vasculitis specifically involving the cardiac valve has been observed and appears to occur in patients with mostly C-ANCA or PR3 antibody positivity, although some cases were reported prior to the use of ANCA testing. Most commonly affected is the aortic valve, followed by the mitral valve, and pathologic assessment of these affected valves yielded nonspecific inflammation and scarring.14

Even more rare is ANCA-associated vasculitis causing vegetations on the cardiac valves, as was the case with our patient. Only a few cases have been reported in the literature (see Table 1).15-22 Our case is unique because the majority of these cases presented with aortic valve vegetations, and our patient had a mobile vegetation on her native mitral valve, which was visualized on echocardiogram.

Table 1: Reported Cases of GPA with a Vegetation on a Cardiac Valve

(click for larger image) Table 1: Reported Cases of GPA with a Vegetation on a Cardiac Valve
*patient had a prosthetic mitral valve from complications of previous rheumatic heart disease
GPA, granulomatosis with polyangiitis; ANCA, anti-neutrophil cytoplasmic antibody; PR3, proteinase 3; TTE, transthoracic echocardiogram; TEE, transesophageal echocardiogram

Ultimately, a combination of findings resulted in the diagnosis of GPA and initiation of immunosuppressive treatment in our patient. The renal biopsy demonstrating crescentic necrotizing glomerulonephritis without the immune complex deposits that would be expected in infective endocarditis and the finding of diffuse alveolar hemorrhage on bronchoalveolar lavage both supported GPA over infective endocarditis. The patient’s negative blood cultures and negative testing for Bartonella, Coxiella, Brucella, HIV and TB, as well as lack of response to the initial antibiotic treatment, all lowered the suspicion for infective endocarditis. The combination of these features and the patient’s response to treatment with high-dose steroids, rituximab and plasma exchange led to the final diagnosis of GPA.

Unfortunately, although the vasculitis appeared to be responding to treatment, the patient was unable to overcome her overall decompensation and, therefore, was unable to survive her illness.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Conclusions

GPA is a small vessel vasculitis that typically affects the respiratory tract and kidneys, with cardiac involvement being uncommon. Patients with small vessel vasculitis can present with signs and symptoms similar to those of infective endocarditis, and a positive ANCA can be seen in both conditions, which further complicates the assignment of a diagnosis. Vegetations on the cardiac valves are typically associated with infective endocarditis and constitute one of the major criteria for its diagnosis. However, valvular vegetations can also result from small vessel vasculitis.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:ANCAantineutrophil cytoplasmic antibodyGPAgranulomatosis with polyangiitis

Related Articles
    Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

    Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

    June 21, 2018

    Granulomatosis with polyangiitis (GPA) was first described in the British Medical Journal in 1897 by Scottish otolaryngologist Peter McBride.1 GPA is a relatively rare, systemic necrotizing vasculitis that can make diagnosis challenging. The incidence has been estimated anywhere between two and 12 cases per million.2 GPA mainly affects adults between the ages of 45 and…

    Case Report: A Patient on Apremilast Develops Streptococcus Salivarius

    October 18, 2019

    Apremilast was first marketed in March 2014 for the treatment of adults with psoriatic arthritis (PsA). An immuno­modulating drug, which is a small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine mono­phosphate (cAMP), apremilast is administered orally. By inhibiting PDE4, intracellular cAMP levels are increased. Although the exact mechanism of action is not…

    Rheumatology’s Architect

    March 1, 2008

    Help the REF lay foundations for our future

    The Granulomatosis of Wegener’s

    May 16, 2011

    Delving deeper into the nonvasculitis aspects of the disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences